Filing Details

Accession Number:
0000902664-24-001290
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-08 16:32:33
Reporting Period:
2024-02-06
Accepted Time:
2024-02-08 16:32:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1999480 Alto Neuroscience Inc. ANRO () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1558858 Alpha Wave Global, Lp 667 Madison Avenue
19Th Floor
New York NY 10065
No No Yes No
2007422 Alpha Wave Ventures Gp, Ltd 667 Madison Ave.
19Th Floor
New York NY 10065
No No Yes No
2009522 Ltd Rsc Holding Lunate Unit 1, Floor 12, Al Maryah Tower
Abu Dhabi Global Market Square
Al Maryah Island, Abu Dhabi C0 00000
No No Yes No
2009884 Chimera Investment Llc Office 410, Royal Group Hdqrtrs Building
Khalifa Park Area
Abu Dhabi C0 00000
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-06 1,962,995 $0.00 1,962,995 No 4 C Indirect See footnotes
Common Stock Acquisiton 2024-02-06 1,144,762 $0.00 3,107,757 No 4 C Indirect See footnotes
Common Stock Acquisiton 2024-02-06 600,000 $16.00 3,707,757 No 4 P Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See footnotes
No 4 C Indirect See footnotes
No 4 P Indirect See footnotes
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Convertible Preferred Stock (Series B Preferred) Disposition 2024-02-06 1,962,995 $0.00 1,962,995 $0.00
Common Stock Series C Convertible Preferred Stock (Series C Preferred) Disposition 2024-02-06 1,144,763 $0.00 1,144,763 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Immediately prior to the closing of the Issuer's initial public offering, each share of Series B Preferred Stock automatically converted into shares of common stock on a 2.1226069 for 1 basis into the number of shares of common stock shown in column 3 and had no expiration date.
  2. Immediately prior to the closing of the Issuer's initial public offering, each share of Series C Preferred Stock automatically converted into shares of common stock on a 2.2241 for 1 basis into the number of shares of common stock shown in column 3 and had no expiration date.
  3. Securities held by Alpha Wave Ventures II, LP ("Alpha Wave Ventures"). Alpha Wave Ventures GP, Ltd ("Alpha Wave Ventures GP") is the general partner of Alpha Wave Ventures. Alpha Wave Ventures GP is a joint venture between Alpha Wave Global, LP ("Alpha Wave") and Lunate Holding RSC LTD ("Lunate"). Lunate is a subsidiary of Chimera Investment LLC ("Chimera," together with Alpha Wave Ventures GP, Alpha Wave and Lunate, the "Reporting Persons"). Richard Gerson is the Chairman and Chief Investment Officer of Alpha Wave. Chimera is controlled by its board of directors.
  4. For purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of such securities for purposes of Section 16 or any other purpose.